News


2/16/2016 Press Release - Tissue Regeneration Therapeutics Grants Excusive License for Perivascular Umbilical Cord Stromal/Stem Cell Technology for Family Banking.
Read More...

1/3/2016 Press Release - TRT receives latest notice of Patent Grant from the State of Israel Patent Office.
Read More...

9/25/2015 Press Release - Tissue Regeneration Therapeutics Inc. Grants Excusive Canadian License for Its Patent: Viable Cells From Frozen Umbilical Cord Tissue, For Family Banking.
Read More...

3/30/2015 Press Release - TRT receives latest notice of Patent Grant from the United States Patent Office.
Read More...

3/24/2015 Press Release - TRT receives latest notice of Patent Grant from the Korean Intellectual Property Office.
Read More...

10/17/2014 Press Release - TRT reaches final milestone of a $3.25 Million funding.
Read More...

6/20/2014 Press Release - TRT Cell-Based Bioweapon Defense Technology Presented at he International Society for Stem Cell Research Conference.
Read More...

6/2/2014 Press Release - Tissue Regeneration Therapeutics Inc. (TRT) and Héma-Québec enter a definitive licensing agreement for the first human clinical trial of TXP-1.
Read More...

7/10/2013 Press Release - Tissue Regeneration Therapeutics Inc. (TRT) raises $3.25 Million to accelerate the development of its Mesenchymal Cell therapeutics platform
Read More...

11/13/2012 University of Toronto - TRT's HUCPVCs Outperform Bone Marrow Cells in Repairing Damaged Hearts
Read More...

11/12/2012 OGI - Ontario Genomics Institute Invests in Stem Cell Technology at Tissue Regeneration Therapeutics
Read More...

10/28/2011 PRESS RELEASE - Tissue Regeneration Therapeutics Grants Exclusive U.S. License for PeriVascular Umbilical Cord Stem Cell Technology to PerkinElmer's ViaCord© Cord Blood Banking Business.
Read More...

6/14/2011 PRESS RELEASE - Trendsetters: Canadian Company Leads Stem Cell Industry in Research and Development
Read More...